Forskning ved Københavns Universitet - Københavns Universitet

Forside

Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease : impact of the epsilon4 allele on regional cerebral blood flow. / Høgh, P; Knudsen, G M; Kjaer, K H; Jørgensen, O S; Paulson, O B; Waldemar, G.

I: Journal of Geriatric Psychiatry and Neurology, Bind 14, Nr. 1, 2001, s. 42-51.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Høgh, P, Knudsen, GM, Kjaer, KH, Jørgensen, OS, Paulson, OB & Waldemar, G 2001, 'Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow', Journal of Geriatric Psychiatry and Neurology, bind 14, nr. 1, s. 42-51. https://doi.org/10.1177/089198870101400110

APA

Høgh, P., Knudsen, G. M., Kjaer, K. H., Jørgensen, O. S., Paulson, O. B., & Waldemar, G. (2001). Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Journal of Geriatric Psychiatry and Neurology, 14(1), 42-51. https://doi.org/10.1177/089198870101400110

Vancouver

Høgh P, Knudsen GM, Kjaer KH, Jørgensen OS, Paulson OB, Waldemar G. Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow. Journal of Geriatric Psychiatry and Neurology. 2001;14(1):42-51. https://doi.org/10.1177/089198870101400110

Author

Høgh, P ; Knudsen, G M ; Kjaer, K H ; Jørgensen, O S ; Paulson, O B ; Waldemar, G. / Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease : impact of the epsilon4 allele on regional cerebral blood flow. I: Journal of Geriatric Psychiatry and Neurology. 2001 ; Bind 14, Nr. 1. s. 42-51.

Bibtex

@article{8d08fa50e3434d5ab310ea5320d69ddf,
title = "Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: impact of the epsilon4 allele on regional cerebral blood flow",
abstract = "The aim of this study was to examine the impact of the apolipoprotein E (APOE) epsilon4 allele on semiquantitative regional cerebral blood flow (rCBF) in Alzheimer's disease. Single photon emission computed tomography technetium (SPECT) with (99m)Tc d,l-hexamethyl propylenamine oxine was used to determine rCBF in 41 consecutive patients (18 males/23 females) with probable Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria (mean age 71.0 years; range 54-85). The mean Mini-Mental State Examination (MMSE) score was 20.4 (range 10-30). After normalization of CBF to mean blood flow in the cerebellum, values for rCBF in several cortical regions of interest, side-to-side asymmetry indices, and anterior-posterior ratios were calculated. Determination of the APOE genotype from blood samples was performed using restriction enzyme polymerase chain reaction technique. Multivariate regression analyses and the Wilcoxon rank-sum test for unpaired data (Mann-Whitney) were used for statistical analysis. The patients comprised 27APOE epsilon4-positive and 14APOE epsilon4-negative individuals. Five patients were APOE epsilon4 homozygotes. APOE epsilon4-positive patients had significantly reduced rCBF in the right frontal and left occipital lobes. On nonparametric analysis, the most prominent differences between epsilon4-negative and epsilon4-positive patients were demonstrated in subregions representing the frontal association cortex (Mann-Whitney, P < .01). Age-stratified analysis suggested that these findings could be demonstrated predominantly in the elderly patients. The results of this study suggest that the APOE genotype in itself may have an impact on the pattern of rCBF deficits in Alzheimer's disease. The more pronounced reduction of rCBF in frontal association cortex observed in elderly APOE epsilon4-positive patients might predict clinical progression.",
keywords = "Age Factors, Aged, Aged, 80 and over, Alleles, Alzheimer Disease/genetics, Apolipoprotein E4, Apolipoproteins E/genetics, Brain/blood supply, Case-Control Studies, Cerebrovascular Circulation/genetics, Dominance, Cerebral/genetics, Female, Frontal Lobe/blood supply, Genotype, Humans, Male, Middle Aged, Occipital Lobe/blood supply, Prognosis, Tomography, Emission-Computed, Single-Photon",
author = "P H{\o}gh and Knudsen, {G M} and Kjaer, {K H} and J{\o}rgensen, {O S} and Paulson, {O B} and G Waldemar",
year = "2001",
doi = "10.1177/089198870101400110",
language = "English",
volume = "14",
pages = "42--51",
journal = "Journal of Geriatric Psychiatry and Neurology",
issn = "0891-9887",
publisher = "SAGE Publications",
number = "1",

}

RIS

TY - JOUR

T1 - Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease

T2 - impact of the epsilon4 allele on regional cerebral blood flow

AU - Høgh, P

AU - Knudsen, G M

AU - Kjaer, K H

AU - Jørgensen, O S

AU - Paulson, O B

AU - Waldemar, G

PY - 2001

Y1 - 2001

N2 - The aim of this study was to examine the impact of the apolipoprotein E (APOE) epsilon4 allele on semiquantitative regional cerebral blood flow (rCBF) in Alzheimer's disease. Single photon emission computed tomography technetium (SPECT) with (99m)Tc d,l-hexamethyl propylenamine oxine was used to determine rCBF in 41 consecutive patients (18 males/23 females) with probable Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria (mean age 71.0 years; range 54-85). The mean Mini-Mental State Examination (MMSE) score was 20.4 (range 10-30). After normalization of CBF to mean blood flow in the cerebellum, values for rCBF in several cortical regions of interest, side-to-side asymmetry indices, and anterior-posterior ratios were calculated. Determination of the APOE genotype from blood samples was performed using restriction enzyme polymerase chain reaction technique. Multivariate regression analyses and the Wilcoxon rank-sum test for unpaired data (Mann-Whitney) were used for statistical analysis. The patients comprised 27APOE epsilon4-positive and 14APOE epsilon4-negative individuals. Five patients were APOE epsilon4 homozygotes. APOE epsilon4-positive patients had significantly reduced rCBF in the right frontal and left occipital lobes. On nonparametric analysis, the most prominent differences between epsilon4-negative and epsilon4-positive patients were demonstrated in subregions representing the frontal association cortex (Mann-Whitney, P < .01). Age-stratified analysis suggested that these findings could be demonstrated predominantly in the elderly patients. The results of this study suggest that the APOE genotype in itself may have an impact on the pattern of rCBF deficits in Alzheimer's disease. The more pronounced reduction of rCBF in frontal association cortex observed in elderly APOE epsilon4-positive patients might predict clinical progression.

AB - The aim of this study was to examine the impact of the apolipoprotein E (APOE) epsilon4 allele on semiquantitative regional cerebral blood flow (rCBF) in Alzheimer's disease. Single photon emission computed tomography technetium (SPECT) with (99m)Tc d,l-hexamethyl propylenamine oxine was used to determine rCBF in 41 consecutive patients (18 males/23 females) with probable Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association criteria (mean age 71.0 years; range 54-85). The mean Mini-Mental State Examination (MMSE) score was 20.4 (range 10-30). After normalization of CBF to mean blood flow in the cerebellum, values for rCBF in several cortical regions of interest, side-to-side asymmetry indices, and anterior-posterior ratios were calculated. Determination of the APOE genotype from blood samples was performed using restriction enzyme polymerase chain reaction technique. Multivariate regression analyses and the Wilcoxon rank-sum test for unpaired data (Mann-Whitney) were used for statistical analysis. The patients comprised 27APOE epsilon4-positive and 14APOE epsilon4-negative individuals. Five patients were APOE epsilon4 homozygotes. APOE epsilon4-positive patients had significantly reduced rCBF in the right frontal and left occipital lobes. On nonparametric analysis, the most prominent differences between epsilon4-negative and epsilon4-positive patients were demonstrated in subregions representing the frontal association cortex (Mann-Whitney, P < .01). Age-stratified analysis suggested that these findings could be demonstrated predominantly in the elderly patients. The results of this study suggest that the APOE genotype in itself may have an impact on the pattern of rCBF deficits in Alzheimer's disease. The more pronounced reduction of rCBF in frontal association cortex observed in elderly APOE epsilon4-positive patients might predict clinical progression.

KW - Age Factors

KW - Aged

KW - Aged, 80 and over

KW - Alleles

KW - Alzheimer Disease/genetics

KW - Apolipoprotein E4

KW - Apolipoproteins E/genetics

KW - Brain/blood supply

KW - Case-Control Studies

KW - Cerebrovascular Circulation/genetics

KW - Dominance, Cerebral/genetics

KW - Female

KW - Frontal Lobe/blood supply

KW - Genotype

KW - Humans

KW - Male

KW - Middle Aged

KW - Occipital Lobe/blood supply

KW - Prognosis

KW - Tomography, Emission-Computed, Single-Photon

U2 - 10.1177/089198870101400110

DO - 10.1177/089198870101400110

M3 - Journal article

C2 - 11281316

VL - 14

SP - 42

EP - 51

JO - Journal of Geriatric Psychiatry and Neurology

JF - Journal of Geriatric Psychiatry and Neurology

SN - 0891-9887

IS - 1

ER -

ID: 260902756